Showing results (11-20 of 71) with videos related to
Sort By:
Pageof 8
Journal of Virology|October 1, 1985
Cross-reactivity between herpes simplex virus glycoprotein B and a 63,000-dalton varicella-zoster virus envelope glycoproteinC M Edson, B A Hosler, R A Respess, et al.The EMBO Journal|June 1, 1987
The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cellsS Swendeman, D A Thorley-LawsonProceedings of the National Academy of Sciences of the United States of America|September 1, 1980
Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivityD A Thorley-Lawson, K GeilingerJournal of Virology|February 1, 1990
Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMPR Moorthy, D A Thorley-LawsonVirology|August 1, 1985
Varicella-zoster virus envelope glycoproteins: biochemical characterization and identification in clinical materialC M Edson, B A Hosler, C A Poodry, et al.Journal of Virology|August 1, 1982
Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivoD A Thorley-Lawson, C A PoodryThe Biochemical Journal|January 1, 1980
Reaction of 1-fluoro-2,4-dinitrobenzene and 2,4,6-trinitrobenzenesulphonic acid with membranes of sarcoplasmic reticulumD A Thorley-Lawson, N M GreenEuropean Journal of Biochemistry|November 1, 1975
Separation and characterisation of tryptic fragments from the adenosine triphosphatase of sarcoplasmic reticulumD A Thorley-Lawson, N M GreenJournal of Virology|February 1, 1995
Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-immortalized B-cell lines and contains an essential NF-kappa B siteL D Klaman, D A Thorley-LawsonThe Journal of Experimental Medicine|July 1, 1985
Early events in Epstein-Barr virus infection provide a model for B cell activationD A Thorley-Lawson, K P MannPageof 8